Israel Englander Abeona Therapeutics Inc. Call Options Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$3.17 - $8.05 $221,900 - $563,500
70,000 Added 233.33%
100,000 $424,000
Q1 2024

May 15, 2024
BUY
$4.07 - $8.68 $122,100 - $260,400
30,000 New
30,000 $217,000
Q2 2023

Aug 14, 2023
BUY
$2.76 - $5.27 $126,959 - $242,419
46,000 New
46,000 $185,000

Others Institutions Holding ABEO

# of Institutions
57
Shares Held
28.6M
Call Options Held
827K
Put Options Held
44.5K
View Full List

About ABEONA THERAPEUTICS INC.

ABEO Quotes by TradingView
  • Ticker ABEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,950,380
  • Market Cap $38.1M
  • Description
  • Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...
More about ABEO
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email